Recursion Pharmaceuticals shares owned by Citadel Advisors
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.5M | 249k | 9.86 |
| 2023-09-30 | $3.6M | 465k | 7.65 |
| 2023-06-30 | $5.8M | 771k | 7.47 |
| 2023-03-31 | $4.3M | 651k | 6.67 |
| 2022-12-31 | $6.1M | 792k | 7.71 |
| 2022-06-30 | $2.9M | 351k | 8.14 |
| 2022-03-31 | $6.7M | 931k | 7.16 |
| 2021-12-31 | $3.7M | 217k | 17.13 |
| 2021-09-30 | $870k | 38k | 23.02 |
| 2021-06-30 | $230k | 6.3k | 36.51 |